Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes

J.R. Dyck^*, P. Schrauwen

^*Corresponding author for this work

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

35 Downloads (Pure)

Original language	English
Pages (from-to)	1069-1070
Number of pages	2
Journal	Biochimica et Biophysica Acta-Molecular Basis of Disease
Volume	1852
Issue number	6
DOIs	https://doi.org/10.1016/j.bbadis.2015.02.002
Publication status	Published - Jun 2015

Access to Document

@article{419ed7839b0142279e087caa710486b1,

title = "Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes",

author = "J.R. Dyck and P. Schrauwen",

year = "2015",

month = jun,

doi = "10.1016/j.bbadis.2015.02.002",

language = "English",

volume = "1852",

pages = "1069--1070",

journal = "Biochimica et Biophysica Acta-Molecular Basis of Disease",

issn = "0925-4439",

publisher = "Elsevier Science",

number = "6",

}

TY - JOUR

T1 - Resveratrol: Challenges in translating pre-clinical findings to improved patient outcomes

AU - Dyck, J.R.

AU - Schrauwen, P.

PY - 2015/6

Y1 - 2015/6

U2 - 10.1016/j.bbadis.2015.02.002

DO - 10.1016/j.bbadis.2015.02.002

M3 - Comment/Letter to the editor

C2 - 25700724

SN - 0925-4439

VL - 1852

SP - 1069

EP - 1070

JO - Biochimica et Biophysica Acta-Molecular Basis of Disease

JF - Biochimica et Biophysica Acta-Molecular Basis of Disease

IS - 6

ER -